Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MediTrials AB
AB
Active
Org 5594934597
Cronquists Gata 1, 214 28
Malmö
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2024
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
MediTrials AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
205
Staff expenses
—
EBITDA
−71
Depreciation & amort.
−0
EBIT
−71
Net financials
—
Profit before tax
−71
Tax
−0
Net profit
−71
Balance sheet
SEK thousands
Item
2025
Total assets
13
Equity
0
Long-term debt
0
Short-term debt
13
Total debt
13
Financial ratios
5-year trend
EBITDA margin
-34.6%
This company
15.8%
Market median
-319% vs market
2025
2025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2025
2025
Return on equity
-7100000.0%
This company
18.4%
Market median
-38587057% vs market
2025
2025
Net profit margin
-34.6%
This company
8.1%
Market median
-527% vs market
2025
2025
Asset turnover
15.77×
This company
1.12×
Market median
+1308% vs market
2025
2025
Debt / equity
12999.00×
This company
0.62×
Market median
-2096513% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
View
PDF
More on MediTrials AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
